Advertisement

Topics

Heron Therapeutics, Inc. Company Profile

22:26 EDT 26th March 2019 | BioPortfolio

Heron Therapeutics is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks. The Company's lead product, Sustol, is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting. For further information, please visit the Company's web site at www.appharma.com.


News Articles [807 Associated News Articles listed on BioPortfolio]

Heron Therapeutics' NDA for HTX─011 receives US FDA priority review status

Heron Therapeutics, Inc, a commercial─stage biotechnology company, announced that the US Food and Drug Administration (FDA) has accepted the new drug application (NDA) for Heron's investigational

FDA speeds up review of Heron's postoperative pain drug

Heron Therapeutics' marketing application for HTX-011, an extended-release formulation of local anesthetic bupivacaine combin -More- 

FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management

SAN DIEGO, Dec. 31, 2018 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm...

Heron seeks FDA nod for postoperative pain drug

A new drug application was filed with the FDA by Heron Therapeutics for HTX-011, which is being developed to manage postopera -More- 

FDA Grants Priority Review Designation for Heron’s HTX-011, a Non-Opioid for Postoperative Pain Management

SAN DIEGO, Dec. 31, 2018 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by develo...

Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management

SAN DIEGO, Oct. 31, 2018 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm...

Heron Therapeutics: Updates To Thesis And PDUFA Date Coming Up

Heron Therapeutics (HRTX) Presents At Evercore ISI HEALTHCONx Healthcare Conference - Slideshow

Drugs and Medications [29 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Sustol [heron therapeutics]

These highlights do not include all the information needed to use SUSTOL safely and effectively. See full prescribing information for SUSTOL.SUSTOL (granisetron) extended-release injection, for subcut...

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

PubMed Articles [467 Associated PubMed Articles listed on BioPortfolio]

Proteomic-based approaches to cardiac development and disease.

Congenital malformations, or structural birth defects, are now the leading cause of infant mortality in the United States and Europe (Dolk et al., 2010; Heron et al., 2009). Of the congenital malforma...

Isolation and genetic characterization of Toxoplasma gondii from free-ranging and captive birds and mammals in Pernambuco state, Brazil.

Recent genetic population studies on Toxoplasma gondii in Brazil have shown large genetic variability. The objective of the present study was to isolate and genotypically characterize T. gondii from f...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Clinical Trials [174 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1316 Associated Companies listed on BioPortfolio]

Blue Heron Biotechnology Incorporated

Blue Heron produces and sells high quality custom reagents for life science research using its proprietary high-throughput manufacturing technologies. Blue Heron's first service, GeneMaker, makes perf...

Heron Health

HERON is a privately held healthcare consultancy founded in the UK in 1999 by Paul Howard, John Kerrigan, and Chris Knight. Following over a decade of growth, the Company is still wholly owned and o...

Heron Therapeutics, Inc.

Heron Therapeutics is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery plat...

BLUE HERON BIOTECHNOLOGY

Blue Heron Bio's GeneMaker® can synthesize any gene regardless of sequence, complexity, or size with 100% accuracy. Save time and money by ordering perfect clones from Blue Heron Bio. Go to ORDERING ...

Blue Heron Capital

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. We...

More Information about "Heron Therapeutics, Inc." on BioPortfolio

We have published hundreds of Heron Therapeutics, Inc. news stories on BioPortfolio along with dozens of Heron Therapeutics, Inc. Clinical Trials and PubMed Articles about Heron Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heron Therapeutics, Inc. Companies in our database. You can also find out about relevant Heron Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record